iSpecimen Inc. 8-K Filing

From the Filing

0001213900-25-113708.txt : 20251121 0001213900-25-113708.hdr.sgml : 20251121 20251121172034 ACCESSION NUMBER: 0001213900-25-113708 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20251119 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20251121 DATE AS OF CHANGE: 20251121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 251509047 BUSINESS ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 8-K 1 ea0266546-8k_ispecimen.htm CURRENT REPORT false 0001558569 0001558569 2025-11-19 2025-11-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): November 19, 2025   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   8 Cabot Road , Suite 1800 Woburn , MA 01801 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.   On November 19, 2025, iSpecimen Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the closing bid price of the Company’s common stock had been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market